NCT06190665View on ClinicalTrials.gov

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

NARecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

DEB-TACE with visualable microspheres

Drug-eluting Beads Transcatheter Arterial Chemoembolization(DEB-TACE) with visualable microspheres

DEVICE

DEB-TACE with PVA microspheres

Drug-eluting Beads Transcatheter Arterial Chemoembolization(DEB-TACE) with polyvinyl alcohol microspheres

Trial Locations (2)

100034

RECRUITING

Peking University First Hospital, Beijing

210009

RECRUITING

Zhongda Hospital，Southeast University, Nanjing

All Listed Sponsors
lead

Zhongda Hospital

OTHER